We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01731769
Recruitment Status : Unknown
Verified November 2012 by Bi-Hongda, Changhai Hospital.
Recruitment status was:  Not yet recruiting
First Posted : November 22, 2012
Last Update Posted : November 22, 2012
Sponsor:
Information provided by (Responsible Party):
Bi-Hongda, Changhai Hospital

Brief Summary:
Axillary dissection is the standard treatment for breast cancer patients with positive nodes. However, seroma formation after axillary dissection remains the most common early complication to breast cancer surgery. It can delay the initiation of adjuvant therapy, predispose to wound infection, delay wound healing and has also been linked to arm lymphoedema. Based on some studies and our experience that vacuum assisted closure (VAC)is effective in complex wound failures following axillary dissection and groin dissection, we use VAC to prevent seroma formation after extensive axillary dissection. This study is aimed to evaluate the efficacy, safety and economics benefits of early VAC application on postoperative complications and wound healing after extensive axillary dissection in comparison to conventional suction drain.

Condition or disease Intervention/treatment
Breast Neoplasms Procedure: vacuum assisted closure in experimental arm Procedure: Axillary dissection

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure--- a Randomized Control Clinical Trial
Study Start Date : January 2013
Estimated Primary Completion Date : January 2013
Estimated Study Completion Date : March 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breast Cancer
U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: Axillary dissection
Axillary dissection is a surgical procedure that incises (opens) the armpit (axilla or axillary) to identify, examine, or remove lymph nodes (small glands, part of the lymphatic system, which filters cellular fluids).
Procedure: Axillary dissection
Experimental: vacuum assisted closure
Vacuum assisted closure (also called vacuum therapy, vacuum sealing or topical negative pressure therapy) is a sophisticated development of a standard surgical procedure, the use of vacuum assisted drainage to remove blood or serous fluid from a wound or operation site.
Procedure: vacuum assisted closure in experimental arm



Primary Outcome Measures :
  1. seroma formation complication incidence [ Time Frame: within the first 30 days (plus or minus 3 days) after surgery ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Written informed consent
  • patients diagnosed with breast cancer, receiving modified radical mastectomy and axillary dissection;
  • Body Mass Index ≥28;
  • drainage volume within the first 48 hours is more than 200 mL.

Exclusion Criteria:

  • Subjects with coagulation disorders shown by exceeding the normal range of any of following: prothrombin time (PT), Quick, activated partial thromboplastin time (aPTT), fibrinogen level, or thrombocytes.
  • Subjects having previously had axillary surgery,
  • Subjects having undergone irradiation therapy to the axillary tissue
  • Subjects having ever received chemotherapy before the surgery,
  • Subjects with known hypersensitivity to components of the surgical sticky membrane

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01731769


Contacts
Contact: Hongda Bi, Ph.D bihongda0411@yahoo.com.cn

Locations
China, Shanghai
Changhai Hospital Not yet recruiting
Shanghai, Shanghai, China, 200433
Contact: Hongda Bi, Ph.D       bihongda0411@yahoo.com.cn   
Sponsors and Collaborators
Changhai Hospital

Responsible Party: Bi-Hongda, attending physician,department of plastic surgery, Changhai Hospital
ClinicalTrials.gov Identifier: NCT01731769     History of Changes
Other Study ID Numbers: PSF-2012
First Posted: November 22, 2012    Key Record Dates
Last Update Posted: November 22, 2012
Last Verified: November 2012

Keywords provided by Bi-Hongda, Changhai Hospital:
Seroma Formation
Axillary Lymph Node Dissection
Breast cancer
Early Vacuum Assisted Closure

Additional relevant MeSH terms:
Breast Neoplasms
Seroma
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases
Inflammation
Pathologic Processes